RPS6KB1 and melanoma: We found that treatment with PTS, both alone and in combination with cisplatin, reduced the expression of the mTOR/S6K1 signaling pathway, resulting in the suppression of the expression of the ZEB1 mRNA (Figure S4), possibly leading to a reduction in the potential for the M5 canine melanoma cells to metastasize.